Wolfgang Hofmann

Title: Wolfgang Hofmann: Innovator in Lentiviral Vector Technology

Introduction

Wolfgang Hofmann is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of genetic engineering, particularly through his work on lentiviral vectors. His innovative approach has the potential to advance gene therapy techniques.

Latest Patents

Hofmann holds a patent for "Episomally replicating lentiviral vectors." This invention is directed to a lentiviral vector system that can be used for episomal replication of a desired gene. The vector system includes a first vector containing a lentiviral gag gene encoding a lentiviral gag protein, a second vector containing an env gene encoding a functional envelope protein, and a lentiviral pol gene encoding a lentiviral pol protein. The pol protein is at least integrase, but it has been modified so that it is not capable of integration. This pol gene can be on the first or second vectors or on a third vector. The lentiviral gag, pol, and envelope protein are not on a single vector, and these vectors do not contain nucleotides to effectively package lentiviral RNA. The system also includes another vector having a nucleic acid sequence encoding a target molecule operably linked to a component of an episomal replicon and a lentiviral packaging sequence. Hofmann's work in this area has led to advancements in gene delivery systems.

Career Highlights

Wolfgang Hofmann is associated with the Dana-Farber Cancer Institute Inc., where he continues to contribute to research and development in cancer therapies. His expertise in lentiviral vector technology has positioned him as a key figure in the field.

Collaborations

Hofmann has collaborated with notable scientists such as Alan Engelman and Joseph G Sodroski. These partnerships have fostered innovation and have been instrumental in advancing research in gene therapy.

Conclusion

Wolfgang Hofmann's contributions to the field of lentiviral vector technology exemplify the impact of innovative thinking in genetic engineering. His patent on episomally replicating lentiviral vectors represents a significant advancement in gene therapy, showcasing his dedication to improving medical science.